Aerzhi

Peking University People's Hospital · Phase 1 active Small molecule

At a glance

Generic name	Aerzhi
Also known as	Sodium Hyaluronate Injection
Sponsor	Peking University People's Hospital
Modality	Small molecule
Therapeutic area	Other
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

A Validation Study of Sodium Hyaluronate in Patients With Periarthritis of Shoulder (NA)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Aerzhi CI brief — competitive landscape report
Aerzhi updates RSS · CI watch RSS
Peking University People's Hospital portfolio CI